158 related articles for article (PubMed ID: 2612238)
1. Therapy of lower respiratory tract infections: a comparison of ceftriaxone and cefotaxime.
Barradas P; Zamith M; Videira W; Cardosa T; Marques RA; Avila R
Chemotherapy; 1989; 35 Suppl 2():33-40. PubMed ID: 2612238
[TBL] [Abstract][Full Text] [Related]
2. [Multicentre, randomized, prospective and comparative study of ceftriaxone, cefotaxime and cefuroxime in treating mild to moderate respiratory tract infection].
Gao B; Hu J; Deng W
Zhonghua Jie He He Hu Xi Za Zhi; 1998 Sep; 21(9):528-31. PubMed ID: 11360502
[TBL] [Abstract][Full Text] [Related]
3. Treatment of lower respiratory tract infections with ceftriaxone and cefotaxime. A comparative study.
Abbate GF; Alagia I; Giaquinto E; Leonessa V; Savioli L; Altucci P; Caputi M; Guarino C; Micillo E; Catena E
Respiration; 1986; 49(3):222-30. PubMed ID: 3515468
[TBL] [Abstract][Full Text] [Related]
4. [Ceftriaxone in the therapy of infections of the lower respiratory tract: comparison with cefotaxime].
Lanni N; Scaglione B
Minerva Med; 1986 Mar; 77(9-10):317-9. PubMed ID: 3485265
[TBL] [Abstract][Full Text] [Related]
5. Comparative clinical evaluation of ceftriaxone in treating lower respiratory tract infections.
Abbate GF; Alagia I; Giaquinto E; Leonessa V; Caputi M; Guarino C; Micillo E; Catena E; Altucci P
Chemioterapia; 1986 Feb; 5(1):26-32. PubMed ID: 3955779
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the efficacy and adverse effect profile of cefotaxime and ceftriaxone in ICU patients with susceptible infections.
Thomas P; Daly S; Misan G; Steele T
Diagn Microbiol Infect Dis; 1992 Jan; 15(1):89-97. PubMed ID: 1730190
[TBL] [Abstract][Full Text] [Related]
7. Once-daily therapy with ceftriaxone compared with daily multiple-dose therapy with cefotaxime for serious bacterial infections: a randomized, double-blind study.
Mandell LA; Bergeron MG; Ronald AR; Vega C; Harding G; Saginur R; Feld R; Duperval R; Landis SJ; Miedzinski LJ
J Infect Dis; 1989 Sep; 160(3):433-41. PubMed ID: 2668427
[TBL] [Abstract][Full Text] [Related]
8. [A well-controlled comparative study on ceftriaxone with cefotaxime in respiratory tract infections].
Kobayashi H; Takamura K; Oshitani H; Nihei T; Saito A; Tomizawa M; Nakayama I; Ishikawa K; Abe M; Kuroda Y
Kansenshogaku Zasshi; 1986 Feb; 60(2):102-24. PubMed ID: 3090162
[No Abstract] [Full Text] [Related]
9. Ceftriaxone therapy of serious bacterial infections.
Eron LJ; Park CH; Goldenberg RI; Poretz DM
J Antimicrob Chemother; 1983 Jul; 12(1):65-78. PubMed ID: 6311783
[TBL] [Abstract][Full Text] [Related]
10. A multicenter, open comparative study of parenteral cefotaxime and ceftriaxone in the treatment of nosocomial lower respiratory tract infections.
Garber GE; Auger P; Chan RM; Conly JM; Shafran SD; Gerson M
Diagn Microbiol Infect Dis; 1992 Jan; 15(1):85-8. PubMed ID: 1730189
[TBL] [Abstract][Full Text] [Related]
11. Comparison of ceftriaxone with cefotaxime in serious chest infections.
Reeves JH; Russell GM; Cade JF; McDonald M
Chest; 1989 Dec; 96(6):1292-7. PubMed ID: 2684552
[TBL] [Abstract][Full Text] [Related]
12. Ceftriaxone monotherapy for severe bacteremic infections. Spanish Ceftriaxone Study Group.
Soriano E; Gatell JM; Aguado JM; Aguirre JM; Arazo P; Arribas JL; Barros C; Cartón JA; Gurgui M; Jiménez E
Chemotherapy; 1989; 35 Suppl 2():27-32. PubMed ID: 2612237
[TBL] [Abstract][Full Text] [Related]
13. Study on the relationship between pharmacokinetics and antibacterial activity: comparison between ceftriaxone and cefotaxime within the respiratory tract.
Fraschini F; Scaglione F
Chemotherapy; 1989; 35(2):77-82. PubMed ID: 2758870
[TBL] [Abstract][Full Text] [Related]
14. Clinical evaluation of ceftriaxone.
File TM; Tan JS; Salstrom SJ
Clin Ther; 1984; 6(5):653-61. PubMed ID: 6090021
[TBL] [Abstract][Full Text] [Related]
15. [Comparative study of intravenous ceftriaxone followed by oral cefixime versus ceftriaxone alone in the treatment of severe upper urinary tract infections].
Regnier B
Presse Med; 1989 Oct; 18(32):1617-21. PubMed ID: 2530546
[TBL] [Abstract][Full Text] [Related]
16. Ceftriaxone versus cefotaxime in the treatment of septicemia in adults.
Ferencz A; Prinz G; Szalka A; Ban E
Chemotherapy; 1989; 35 Suppl 2():5-9. PubMed ID: 2612239
[TBL] [Abstract][Full Text] [Related]
17. A comparison of ampicillin/sulbactam versus cefotaxime in the therapy of lower respiratory tract infections in hospitalized patients.
Jauregui L; Minns P; Hageage G
J Chemother; 1995 Apr; 7(2):153-6. PubMed ID: 7666123
[TBL] [Abstract][Full Text] [Related]
18. Ceftriaxone compared with cefotaxime for serious bacterial infections.
Smith CR; Petty BG; Hendrix CW; Kernan WN; Garver PL; Fox K; Beamer A; Carbone K; Threlkeld M; Lietman PS
J Infect Dis; 1989 Sep; 160(3):442-7. PubMed ID: 2668428
[TBL] [Abstract][Full Text] [Related]
19. [Evaluation and perspectives of a new cephalosporin: ceftriaxone].
Auvergnat JC; Armengaud M
Rev Med Interne; 1985 Mar; 6(2):187-92. PubMed ID: 3839091
[TBL] [Abstract][Full Text] [Related]
20. Cefotaxime twice daily versus ceftriaxone once daily. A randomized controlled study in patients with serious infections.
Simmons BP; Gelfand MS; Grogan J; Craft B
Diagn Microbiol Infect Dis; 1995; 22(1-2):155-7. PubMed ID: 7587031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
